Piroxicam in recent epidemiologic studies.
Data from nine epidemiologic studies indicate that nonsteroidal anti-inflammatory drugs as a class are much better tolerated by the gastrointestinal tract than is aspirin, and that piroxicam, specifically, is at least as well tolerated as other nonsteroidal anti-inflammatory drugs.
D000367:Age Factors; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D003625:Data Collection; D004813:Epidemiology; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007256:Information Systems; D009026:Mortality; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000453:epidemiology; D010894:Piroxicam / Q000009:adverse effects* / Q000627:therapeutic use; D011358:Product Surveillance, Postmarketing; D012107:Research Design / Q000379:methods
D000894:Anti-Inflammatory Agents, Non-Steroidal; D010894:Piroxicam